Latest News


ACTSI-supported Start-up Update: NeurOp

Created in 2007 as one of a national consortium striving to improve the way biomedical research is conducted across the country, the Atlanta Clinical & Translational Science Institute (ACTSI) works to break down obstacles in the translational...


Science Advance: Association Between Living in Food Deserts & Cardiovascular Risk, an Atlanta Study

Several Georgia CTSA-supported researchers used existing data from Georgia CTSA’s Center for Health Discovery & Well Being and the Morehouse and Emory Team up to Eliminate Health Disparities (META)-Health Study to build a cohort of...


CTSA Offers Study Design for Belatacept Clinical Trial

ACTSI's biostatistics program developed an optimal three-stage group sequential design for monitoring the safety of the clinical trial Bela 8 Week Dosing. The trial is examining immunosuppression therapy in post-transplant kidney recipients and is...


Georgia Clinical & Translational Science Alliance receives $51 million NIH state-wide grant

After a decade of research collaboration, the Atlanta Clinical & Translational Science Institute (ACTSI) will welcome a new partner and change its name, reflecting a new statewide focus. The University of Georgia will officially become the...


Emory i2b2 Update

Georgia CTSA has updated Emory i2b2 to version 1.7.08a. Emory I2b2 is a study feasibility assessment tool that lets you quickly determine how many Emory Healthcare patients might be eligible for your planned study, and how different inclusion and...


Two New R01 Awards will Develop Methods of Alleviating Kidney Transplant Disparities

Rachel Patzer, PhD, MPH, former Georgia Clinical & Translational Science Alliance (Georgia CTSA) KL2 scholar and Georgia CTSA Master of Science in Clinical Research (MSCR) instructor, associate professor of surgery and epidemiology at Emory...

Upcoming Events

View All Events